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EQA SCHEME FOR HORMONE IMMUNOASSAY: EVALUATION OF LABORATORY PERFORMANCE
THROUGH A SCORING SYSTEM
A. Pilo, G.C. Zucchelli, M.R. Chiesa, R. Conte, A. Mercuri, M. Scarlattini, F. Cantini
CNR Institute of Clinical Physiology, Pisa
The Extemal Quality Assessment (EQA) scheme Immunocheck for hormone immunoassay has been organised by
our Institute since 1996 in co-operation with ProBioQual (Lyon, France); at present time more than 1000 laboratories
are involved in the scheme which includes 18 analytes. Participants assay 18 conhol samples every year; statistics of the
collected results are circulated sending back to the laboratories periodic and cumulative reports. To allow participants an
easy evaluation of their own analytical pedormance, a new scoring system has been adopted. Each result is scored
according to its deviation (Aom target value) expressed in SD units (Z-score). In detail the scores are: 4(excellent) if Z
<0.5, 3(good) if 05<Z<1,2(sufficient) iî l<Z<2, 1(inadequate) if 2<Z<3, -2(outlier) ifZ >3.The sum of scores for all
samples assayed in a contlol cycle, normalised by the maximum achievable total score, describes the analytical
performance of the laboratory.
Z-score is computed as the ratio of peîcent deviation from target and "state-of-the-art ' imprecision. Method mean is
assumed as target; state-of-the-aît imprecision is computed as mean imprecision of the methods most used in the suvey.
To take account that imprecision depends on the analyte concentuation, 3 CVs are computed corresponding to 3
concentration range. The follov/ing table reports for each analyte the concenhation ranges and the state-of-the-art CVs
(within-method, betweenlaboratories imprecision) computed from the lmmunocheck data-base (results collected dufing
2001 EQA cycle).
T3 (nglril,)
T3ftee (pg/ml-)
T4 (microg/dl)
T4free (pg/ml-)
TSH (microlU/ml)
LH (nIU/mL)
FSH (mIU/mL)
HCG (riluftril,)
Prolactin (microru/ml-)
Fenitin (ng/ml-)
HGH (microlU/ml)
Insulin (microlU/ml)
Aldosterone (pg/ml)
Cortisol (microg/ml)
DHEA-S (microg/ml)
Estadiol (pglml-)
Progesterone (nglml-)
Testostèrone (nglml-)
low
<0.9
<3
<6
<10
<0.7
>15
<24
<200
<25
<5
<20
<90
< 1 0
< 1
<60
< 1 . 8
<0.7
o.9-2.O
J-O
6-10
t0-20
0.7 -5
7-20
t5-25
24-tOO
200-60Q
25-ll0
20-40
90-220
10- 18
60-350
1.8-8
0.7 -7 .5
>2.0
>6
>10
>20
>7
>20
>25
>100
>600
> l  l 0
> 1 5
>40
>220
> 1 8
>2.5
>350
>8
>7.5
low
14.3Vo
tt.?va
ll.l%o
8.7Vo
8.5Va
8-4Vo
7.4Va
9.8Vo
13.3Vo
14.ÙVo
20.4V.
13.8Vo
29.7Vo
ll.0Vo
22.9Vo
26.ÙVo
l6.9Vo
2919Vo
Concentation range
medium high
State-of-the-art CV
rnediu high
m
9.4Vo 7 .4E
7 .1Vo 7.4Vo
8.4Vo 8.2Vo
6.9Vo 7.67o
7 .4Vo 7 .2Vo
7 -lVo 7 -2Vo
6.9Vo 7 .l%o
9.3Vo 7 .9Vo
9.0V0 9.4Vo
ll.1%o 10.0Vo
9.4Va 12.6Vo
l0.2Vo 1l.4Vo
14.6%o 12.8V.
9.3Vo 9.6Vo
17 .97o l'7 .OVo
ll.2%o 9.7Vo
l0.97o 8.9Vo
I2.5Vo l2.3Vo
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